Diagnostic Microbiology Development Program (EIN 264160971) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

James C McLaughlin PhD

Phone

4157227629

Tax Period

2022-01-01 to 2022-12-31

Mission

Support the development of diagnostic microbiology laboratories in resource limited countries by providing supplies, equipment, training of laboratory staff and ongoing technical support.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $0

Expense Breakdown

Grants Paid $0

Salaries & Benefits $664,359

Fundraising Expenses $0

Program Expenses $1,090,491

Other Expenses $522,872

TOTAL EXPENSES $1,187,231

Year-over-Year Comparison

	2022	2021	Change
Revenue	N/A	$421,873	-1.0%
Expenses	$1,187,231	$2,210,846	-0.5%
Net Income	N/A	$-1,788,973	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$117,141

Total Directors

$117,141

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
John Ridderhof DrPH	President	40.00	Officer Director	$75,797	$0	$75,797
James C McLaughlin PhD	Treasurer	40.00	Officer Director	$41,344	$0	$41,344
Robyn Devenish	Board Member	8.00	Director	$0	$0	$0
John Ferguson	Board Member	8.00	Director	$0	$0	$0
Lucy Perrone	Board Member	8.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	No data	$1,187,231	$608,696	No data
2021	$421,873	$2,210,846	$1,798,354	$-1,788,973
2020	$1,778,093	$2,017,629	$3,585,660	$-239,536
2019	$2,289,575	$1,919,453	$3,911,059	$370,122
2018	$3,227,956	$2,331,989	$3,440,940	$895,967

Diagnostic Microbiology Development Program